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  24 
Abstract 25 
 26 
Background: Hyperthyroidism is common in older cats, which necessitates frequent 27 
screening of serum total thyroxine (TT4) concentrations. Fast, cheap, and reliable ways to 28 
measure TT4 in cats are needed. 29 
Objectives: Validation of a human TT4 enzyme immunoassay (EIA) for use with feline 30 
serum and derivation of a TT4 reference interval (RI) for cats aged 9 years and older). 31 
Methods: Assay precision, reproducibility, and linearity were evaluated. Interference by 32 
hemolysis was also assessed. Method comparison studies between the EIA and previously 33 
validated radioimmunoassay (RIA) and chemiluminescent-enzyme immunoassay (CEIA) 34 
were performed. Healthy cats (>9 years) were recruited from three UK first opinion practices. 35 
Results: The human TT4 EIA demonstrated good precision and reproducibility and adequate 36 
linearity. Hemolysis did not significantly alter measured TT4 concentrations until 37 
hemoglobin concentration exceeded 8 g/L. Method comparison revealed proportional and 38 
constant error between EIA and RIA/CEIA. The TT4 RI for cats (>9 years) was calculated as 39 
7.1-45.1 nmol/L (n=49). 40 
Conclusions: The human TT4 EIA was successfully validated for use with feline serum and 41 
offers a rapid, cheap and reliable method for determination of serum TT4 concentrations in 42 
cats. 43 
 44 
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  48 
Introduction 49 
 50 
Hyperthyroidism is the most common feline endocrinopathy, with a prevalence of 6% in cats 51 
aged over 9 years.
1
 Routine screening of senior and geriatric cats for hyperthyroidism is 52 
recommended,
2
 which has led to increasing demand for the measurement of serum total 53 
thyroxine (TT4) concentrations in cats. As a result, there is a need to identify methods of TT4 54 
measurement which are rapid, cheap and reliable. Both radioimmunoassays (RIA) and 55 
chemiluminescent-enzyme immunoassays (CEIA) for TT4 have been validated for use in 56 
cats,
3,4
 however, both methods are costly to perform and require additional analysers which 57 
are expensive to purchase and maintain. An automated, homogeneous enzyme immunoassay 58 
(EIA) for the measurement of serum TT4 in cats, which can be run on automated 59 
biochemistry analysers, has been validated.
5
 However, the previously validated EIA is not 60 
commercially available at present. Although an alternative human EIA
a
 is available, this uses 61 
a different methodology to the previously validated EIA.
5,b 
62 
   Diagnosis of feline hyperthyroidism is usually based on documentation of an elevated 63 
serum TT4 concentration, however some hyperthyroid cats can have a serum TT4 64 
concentration in the high normal range, perhaps secondary to non thyroidal illness.
6
 It is also 65 
possible that the reference intervals (RI) currently utilised for TT4 in cats are inappropriate 66 
for senior and geriatric cats. The ASVCP guidelines for the determination of de novo 67 
reference intervals in veterinary species
7
 recommend that “the demographics of the reference 68 
population should be representative of the patient population for which the RI will be used in 69 
making clinical decisions.” Hence, a RI for TT4 should be derived exclusively from a 70 
population of senior and geriatric cats, since this is the population that is usually tested for 71 
hyperthyroidism.    72 
   The primary aim of the present study was to validate a commercially available human TT4 73 
EIA
a
 for use with feline serum. The secondary aim was to compare the performance of a 74 
human TT4 EIA against the performance of both the radioimmunoassay (RIA) and 75 
chemiluminescent-enzyme immunoassay (CEIA) for TT4 in cats. The final aim was to 76 
establish a TT4 RI from a population of clinically healthy cats aged over 9 years in three UK 77 
based first opinion practices, since this should serve as a more appropriate RI for TT4 in this 78 
population. Utilisation of an appropriate RI for TT4 may also increase the sensitivity of TT4 79 
for diagnosis of hyperthyroidism. 80 
 81 
Materials and methods 82 
 83 
Blood and urine samples were obtained from cats (n=134) at three UK first opinion practices 84 
as part of a free of charge screening programme for cats aged >9 years. The Ethics and 85 
Welfare Committee of the Department of Veterinary Medicine, University of Cambridge 86 
approved the use of residual patient samples for research purposes (Project approval CR56 87 
and CR77). Complete blood count, serum biochemistry (including total thyroxine 88 
concentration (TT4) by EIA) and urinalysis (including urine protein: creatinine ratio (UPC)) 89 
were performed. In addition, serum samples from cats which presented to the Queen’s 90 
Veterinary School Hospital, University of Cambridge or the RSPCA Clinic, Cambridge were 91 
used. All samples had TT4 determined by RIA or CEIA at the time of submission, with 92 
excess serum sample stored for up to 18 months at -80
o
C until batch analysis of TT4 by EIA. 93 
   The EIA,
a
 which is primarily designed for the measurement of TT4 in human serum, was 94 
performed by an automated biochemistry analyser
c 
using standard programming data and 95 
instructions provided by the manufacturer. The EIA uses 8-anilino-1-naphthalene sulfonic 96 
acid to dissociate thyroxine from binding proteins. The dissociated thyroxine in the sample is 97 
then allowed to compete with glucose-6-phosphate dehydrogenase (G6PDH) labelled 98 
thyroxine for a fixed amount of anti-thyroxine specific antibody sites in the solution. In the 99 
absence of thyroxine in the sample, the G6PDH labelled thyroxine is bound by the specific 100 
antibody and the enzyme activity is inhibited, thus this creates a direct relationship between 101 
enzyme activity in the sample and the TT4 concentration. Enzymatic activity of G6PDH is 102 
determined spectrophotometrically at 340nm by measuring the ability of G6PDH to convert 103 
nicotinamide adenine dinucleotide (NAD) to NADH. The human TT4 calibrators provided 104 
with the assay kit were used for assay calibration, with an additional calibrator (12.9 nmol/L) 105 
also added, which was made by dilution of the highest calibrator provided with the kit (258 106 
nmol/L). 107 
   Precision and repeatability of the EIA was assessed by evaluating intra- and inter-assay 108 
coefficients of variation for serum samples with low, medium and high serum TT4 109 
concentrations. For intra-assay precision three replicates of each sample were evaluated 110 
within the same run. For assessment of inter-assay variability, pooled feline serum samples 111 
were evaluated in duplicate on three consecutive working days. The limit of blank was 112 
determined by measurement of the TT4 in deionised water (diH2O), which was evaluated in 113 
triplicate on three consecutive working days. The limit of blank was calculated as the mean 114 
interpolated TT4 concentration in diH2O + 2*standard deviation of TT4 in diH2O.
8
 The lower 115 
limit of quantitation was calculated as the lowest concentration at which TT4 could be 116 
detected with a CV <20% when samples were analysed in triplicate. Linearity was evaluated 117 
using feline serum pools of high, medium and low TT4 concentrations (151.1 nmol/L, 96.6 118 
nmol/L, 86.4 nmol/L, 11.6 nmol/L and 3.9 nmol/L), with dilution samples prepared by 119 
mixing the high or medium, and low pooled samples. The linearity was determined by 120 
comparing the observed TT4 concentrations following dilution with the expected (calculated) 121 
TT4 concentrations. Interference by hemolysis was determined by addition of feline blood 122 
hemolysate to feline serum samples. The hemolysate was prepared by washing of feline 123 
erythrocytes three times in saline, before hemolysis of the erythrocytes by addition of diH2O. 124 
The hemolysate was sequentially added to the serum samples, with the final hemoglobin 125 
concentration of the serum determined spectrophotometrically.
d 
Expected TT4 concentrations 126 
were calculated in order to correct for dilution of the sample following addition of the 127 
hemolysate. 128 
   For the method comparison studies, a mixed population of hyperthyroid and euthyroid cats 129 
was used. Diagnosis of hyperthyroidism was based on a TT4 >55 nmol/L (by CEIA) or >65 130 
nmol/L (by RIA). TT4 measurements were made by RIA
e
 and CEIA
f
  at two commercial 131 
laboratories.
g,h 
Method comparison was performed between the EIA and RIA, and the EIA 132 
and CEIA by Deming regression analysis using commercially available software,
i
 and by 133 
construction of Bland-Altman plots.
9
 Samples with a TT4 >154 nmol/L by EIA (upper limit 134 
of dynamic range of assay) were excluded from the method comparison studies.
 
135 
   Cats recruited to the healthy control group had blood and urine samples taken as part of a 136 
free of charge screening programme for cats aged over 9 years. Haematology, routine 137 
biochemistry, urinalysis (including urine sediment examination) and TT4 (by RIA or CEIA) 138 
were performed on all cats. To be included in the healthy control group for derivation of the 139 
RI for TT4, cats had to have no clinical history of disease, and have no significant 140 
abnormalities on clinical examination reported by the attending veterinarian, other than dental 141 
disease, entropion or presence of a systolic heart murmur (without evident congestive heart 142 
failure). Cats with evidence of renal azotemia (serum creatinine concentration >153 µmol/L 143 
with urine specific gravity <1.035), TT4 >55 nmol/L or >65 nmol/L (by CEIA or RIA 144 
respectively), or with evidence of pyuria or bacteriuria, were excluded from the healthy 145 
control group. The TT4 RI was determined from the cats that were included in the healthy 146 
control group using computerised software,
j,10
 which calculated the lower and upper limits of 147 
the TT4 reference interval by the robust method using Box-Cox transformed data. The 90% 148 
confidence intervals (CI) for the upper and lower limits of the reference interval were also 149 
reported. 150 
 151 
Results 152 
 153 
Inter- and intra-assay precision were acceptable (CV <12%) at all levels tested (Table 1). The 154 
assay was linear in the range of 5.6-151 nmol/L (r
2
=0.997, Figure 1) with acceptable analyte 155 
recovery (<18% deviation from calculated value at any point) throughout the range of TT4 156 
concentrations tested. The limit of blank was calculated to be 6.3 nmol/L and the lower limit 157 
of quantitation was calculated to be 6.9 nmol/L. Hemolysis of the sample up to 8 g/L 158 
(consistent with 3+ hemolysis grossly) did not result in significant changes to the TT4 159 
concentration, although hemolysis at 15 g/L did result in a 27% increase in the measured TT4 160 
concentration when compared with the calculated TT4 concentration (Table 2). 161 
   For the method comparison studies, a population of 56 hyperthyroid cats was used, which 162 
had a median age of 14.8 years (interquartile range 12.6-16.1 years). The population of 163 
hyperthyroid cats consisted of 31 female neutered cats and 25 male neutered cats, and all 164 
were domestic short or long haired cats. When comparing the EIA with the RIA (n=36, 11/36 165 
were hyperthyroid cats) revealed proportional error (slope 1.27, 95% CI 1.02-1.53) but no 166 
significant constant error (intercept 1.40, 95% CI -8.34 - 11.13). Correlation between the EIA 167 
and RIA was good (r=0.945, Figure 2) and the Bland Altman plots demonstrated that in the 168 
majority of cases, the difference between the EIA and RIA TT4 concentrations was within 2 169 
standard deviations of the mean difference between the methods (Figure 3). Method 170 
comparison between the EIA and CEIA (n=81, 43/81 were hyperthyroid cats) revealed 171 
proportional (slope 1.16, 95% CI 1.12 - 1.19) and constant error (intercept -4.04, 95% CI -172 
6.07 - -2.01). Correlation between the EIA and CEIA was good (r=0.987, Figure 4) and the 173 
Bland Altman plots demonstrated that in the majority of cases, the difference between the 174 
EIA and RIA TT4 concentrations was within 2 standard deviations of the mean difference 175 
between the methods (Figure 5) . 176 
   Within the healthy reference population, there were 26 female neutered cats and 23 male 177 
neutered cats with a median age of 12 years (interquartile range 11-14 years). The majority of 178 
cats (n=43) were domestic short or long haired cats, and six other breeds (Burmese, Bengal, 179 
Devon Rex, Persian, Russian Blue and Siamese) were also represented (n=1 for each breed). 180 
Six cats were diagnosed with pre-renal azotemia (serum creatinine concentration >153 181 
µmol/L with concurrent urine specific gravity ≥ 1.035), and 13 cats had an elevated serum 182 
ALT activity (>62 IU/L, range 66-193 IU/L), however no cats had an increased serum ALP 183 
activity (>93 IU/L). The TT4 of the healthy cats aged over 9 years ranged between <6.9 184 
nmol/L and 50.3 nmol/L (Figure 6) and the RI was calculated to be 7.1-45.1 nmol/L (n=49). 185 
The 90% CI for the lower and upper limits of the TT4 RI were 4.3-10.6 nmol/L and 40.1-50.3 186 
nmol/L respectively. 187 
   When cats with an EIA TT4 >45.1 nmol/L were compared with cats with a TT4 >65 188 
nmol/L by RIA, there was diagnostic agreement in 31/36 cases (86%, Figure 2), and all 189 
discordant cases had a TT4 concentration close to the upper reference limit for the EIA or 190 
RIA. When cats with an EIA TT4 >45.1 nmol/L were compared with cats with a TT4 >55 191 
nmol/L by CEIA, there was diagnostic agreement in all 81 cases (Figure 4).  192 
 193 
Discussion 194 
 195 
The EIA for TT4 demonstrated excellent precision and reproducibility at medium and high 196 
concentrations of TT4, and good precision and reproducibility at low TT4 concentrations. 197 
The critical decision limit for TT4 is approximately 50-60 nmol/L in cats (for the diagnosis of 198 
hyperthyroidism) and at these concentrations the assay performance was excellent. Linearity 199 
of the assay was also demonstrated with feline serum. Hemolysis (at clinically relevant 200 
concentrations) did not appear to significantly alter the measured serum TT4 concentrations, 201 
although very marked hemolysis did artefactually increase the TT4 concentration. 202 
Unfortunately the effect of lipemia on the measured serum TT4 concentration was not 203 
assessed as part of the present study, and should be investigated in future studies. 204 
   The method comparison study demonstrated proportional and/or constant error between the 205 
methods, with the EIA generally underestimating the TT4 concentration compared with the 206 
RIA and CEIA. This indicated that reference intervals could not be transferred between 207 
methods, and thus a new reference interval for the EIA was required. It is possible that 208 
storage of serum at -80
o
C for up to 18 months might have resulted in a decrease in the 209 
measured TT4, which could account for the tendency for the EIA to underestimate the TT4 210 
when compared with the RIA and CEIA. Storage of serum at -20
o
C for up to 35 days does 211 
not significantly alter the measured TT4 concentration,
5
 however further studies to 212 
investigate the effect of prolonged storage at -80
o
C on the measured serum TT4 concentration 213 
are warranted. The method comparison studies did, however, demonstrate that there was 214 
good diagnostic agreement between the EIA and RIA/CEIA. In the present study, it was 215 
impossible to determine if the EIA was better at diagnosing hyperthyroidism than the RIA or 216 
CEIA, as this would require another gold standard method to be used for the diagnosis of 217 
hyperthyroidism, such as scintigraphy. 218 
   The calculated upper reference limit for TT4 of 45.1 nmol/L (by EIA), was lower than the 219 
upper limit of the reference interval reported for the RIA and CEIA methods (65 and 55 220 
nmol/L respectively). Samples included in the reference interval were not stored at -80
o
C and 221 
therefore will not have been subject to pre-analytical error. This lower value may partly 222 
reflect the relatively small number of animals that were included in the reference population 223 
in the present study (n=49), or may reflect a more appropriate upper reference interval limit 224 
for cats aged over 9 years. Older cats are more likely to have concurrent non thyroidal illness 225 
(such as dental disease) which might decrease serum TT4 concentrations, therefore a 226 
reference interval for TT4 derived exclusively from older cats might be expected to be lower 227 
than a reference interval generated from a more heterogeneous population which included 228 
younger, healthier cats. 229 
   Cats with an isolated high ALT without other clinical evidence of hepatic disease were not 230 
excluded from the healthy control group because; the cats demonstrated no clinical signs of 231 
hepatic disease, the elevation in ALT was a relatively frequent finding (occurring in 13 cats), 232 
and the elevations in ALT that were observed were relatively mild (<2x upper limit of 233 
reference interval) in the majority of cases. Based on this, it seems unlikely that many of 234 
these cats had significant hepatocellular disease, however the presence of hepatic disease, 235 
which might have suppressed TT4 concentrations, could not be excluded fully without further 236 
invasive investigations such as liver biopsy and histopathology. 237 
   In conclusion, a human TT4 EIA was successfully validated for use with feline serum and 238 
offers a rapid, cheap and reliable method for determination of serum TT4 concentrations in 239 
cats. The EIA appears to underestimate the TT4 concentration compared with the RIA and 240 
CEIA, and the RI for TT4 in cats aged over 9 years was also lower than the reference range 241 
reported for the RIA and CEIA. Further studies are warranted to investigate if the age specific 242 
RI for cats reported in this study increases the sensitivity of TT4 for the diagnosis of 243 
hyperthyroidism. 244 
 245 
 246 
  247 
Footnotes 248 
 249 
a
 DRI Thyroxine Assay, Microgenics Corporation, Freemont, CA, USA. 250 
b
 CEDIA Total T4 Assay, Boehringer Mannheim Corp., Indianapolis, IN, USA.  251 
c
 Olympus AU400, Beckman Coulter, High Wycombe, UK. 252 
d
 Sysmex XT-2000iV, Sysmex Corporation, Hyogo, Japan.   253 
e 
Gamma Coat M total T4 radioimmunoassay, DiaSorin Inc, Stillwater, Minn. 254 
f
 IMMULITE Total T4, Siemens Healthcare, Camberley, UK. 255 
g
 Nationwide Specialist Laboratories, Stapleford, Cambridge, UK. 256 
h
 IDEXX Laboratories, Wetherby, UK. 257 
i
 MedCalc Statistical Software version 14.8.1, MedCalc Software bvba, Ostend, Belgium. 258 
j
 Reference Value Advisor version 2.1 (http://www.biostat.envt.fr/spip/spip.php?article63)    259 
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  289 
Figure 1. Linearity of the human enzyme immunoassay (EIA) for serum total thyroxine 290 
concentration (TT4) using pooled feline serum with low and high TT4 concentrations. The 291 
line of equality is shown. 292 
 293 
Figure 2. Method comparison of radioimmunoassay (RIA) and enzyme immunoassay (EIA) 294 
for feline serum total thyroxine concentration (TT4). The solid line represents the line of 295 
equality. The dotted lines represent the upper limits of the reference intervals for the RIA and 296 
EIA. 297 
 298 
Figure 3. Bland Altman plot showing the difference between the measured serum total 299 
thyroxine concentration (TT4) by the radioimmunoassay (RIA) and enzyme immunoassay 300 
(EIA) against the average TT4 measured by the RIA and EIA. The solid line represents the 301 
mean difference between the methods and the dotted lines present the mean ± 2 x standard 302 
deviation difference between the methods. 303 
 304 
Figure 4. Method comparison of enzyme immunoassay (EIA) and chemiluminescent-enzyme 305 
immunoassay (CEIA) for feline serum total thyroxine concentration (TT4). The solid line 306 
represents the line of equality. The dotted lines represent the upper limits of the reference 307 
intervals for the EIA and CEIA. 308 
 309 
Figure 5. Bland Altman plot showing the difference between the measured serum total 310 
thyroxine concentration (TT4) by the chemiluminescent-enzyme immunoassay (CEIA)  and 311 
enzyme immunoassay (EIA) against the average TT4 measured by the RIA and CEIA. The 312 
solid line represents the mean difference between the methods and the dotted lines present the 313 
mean ± 2 x standard deviation difference between the methods. 314 
 315 
Figure 6. Scatter plot showing the serum total thyroxine (TT4) concentrations of 49 healthy 316 
cats aged over 9 years. The dotted lines indicate the lower and upper limits of the calculated 317 
reference interval for TT4 in cats aged over 9 years (7.1-45.1 nmol/L). 318 
 319 
 320 
 321 
 322 
  323 
Table 1. Intra- and inter-assay coefficients of variation (CV) at low, medium and high 324 
serum concentrations of feline total thyroxine (TT4) calculated using a human TT4 325 
enzyme immunoassay. 326 
 327 
 
TT4 
concentration 
Intra-assay variability (n=3) Inter-assay variability (n=3) 
Mean TT4 
concentration 
(nmol/L) 
Range of TT4 
concentrations 
observed 
(nmol/L) 
CV 
(%) 
Mean TT4 
concentration 
(nmol/L) 
Range of TT4 
concentrations 
observed 
(nmol/L) 
CV 
(%) 
Low 11.2 9.8-12.2 11.0 10.2 9.0-12.2 10.5 
Medium  54.0 53.2-55.1 1.8 56.0 54.0-58.8 4.5 
High 137.5 135.4-140.0 1.7 139.6 137.0-141.7 1.5 
 328 
 329 
  330 
Table 2. Effect of hemoglobin concentration on feline serum total thyroxine (TT4) 331 
concentrations measured by a human TT4 enzyme immunoassay. 332 
 333 
Hemoglobin 
concentration of 
serum (g/L) 
Calculated serum 
TT4 concentration 
(nmol/L) 
Observed serum TT4 
concentration 
(nmol/L) 
Recovery (%) 
5 62.2 66.3 107 
8 48.4 47.8 99 
15 26.9 34.1 127 
 334 
 335 
